severe aplastic anemia

Novartis' blood disorder drug gets FDA approval for expanded use
Reuters
Mon, 11/19/18 - 11:39 pm
Novartis
Promacta
FDA
severe aplastic anemia
Gamida Cell launches severe aplastic anemia trial
Drug Delivery Business News
Tue, 08/22/17 - 12:01 am
Gamida Cell
severe aplastic anemia
CordIn
GlaxoSmithKline Wins Another FDA ‘Breakthrough’ Designation
Wall St Cheat Sheet
Mon, 02/3/14 - 03:56 pm
GSK
FDA
breakthrough therapies
severe aplastic anemia
Promacta
Revolade